https://www.selleckchem.com/pr....oducts/hygromycin-b.
Pooled 12-month primary patency per limb was 90% (143/160; 95% confidence interval [CI] 0.84-0.95), freedom from CD-TLR 96% (124/130; 95% CI 0.91-0.99), limb salvage rate 97% (156/160; 95% CI 0.94-1.0, survival rate 90% (112/125; 95% CI 0.82-0.96), and AFS rate 89% (110/125; 95% CI 0.81-0.94). Subgroup analyses of included Absorb BVS studies showed similar results. All studies were assessed as moderate quality. This meta-analysis of case series showed good 12-month patency and clinical results with BVSs for BTK arterial disease,